Effect of supplementation in treatment of patients with gestational diabetes

Phase 3

Conditions: Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
O24.9

Registration Number: IRCT201605135623N78

Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 140

Inclusion Criteria

Patients with gestational diabetes in the age range of 18 to 40 years

Exclusion Criteria

Taking vitamin D and/or omega-3 fatty acids supplements
Taking insulin
Placenta abruption
Preeclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers
Kidney or liver diseases

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: ELISA test.

Secondary Outcome Measures

Name	Time	Method
Triglycerides. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;Total cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;LDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;VLDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;FPG. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.